staphylococcu
aureu
one
primari
caus
commun
nosocomi
bacteri
infect
human
rosenth
et
al
aureu
account
superfici
invas
infect
bacteria
lead
consider
morbid
mortal
worldwid
hakim
et
al
haupt
et
al
number
aureu
surfac
protein
enabl
microb
adher
invad
host
cell
well
evad
immun
defenc
mechan
bur
et
al
clump
factor
clfa
categor
member
microbi
surfac
compon
recogn
adhes
matrix
molecul
mscramm
famili
shown
major
virul
factor
mani
anim
model
includ
crucial
cellsurfaceanchor
virul
factor
aureusinduc
sepsi
mcadow
et
al
clfa
mediat
adhes
aureu
host
tissu
bind
extracellular
matrix
protein
fibrinogen
mccormack
et
al
particip
imped
macrophag
phagocytosi
well
stimul
platelet
aggreg
fibrin
clot
format
kerrigan
et
al
palmqvist
et
al
laboratori
previous
shown
clfa
recruit
plasma
complement
regulatori
protein
factor
result
inhibit
complementmedi
opsonophagocytosi
hair
et
al
hair
et
al
plasma
apolipoprotein
apo
central
therapeut
target
play
vital
role
macrophag
biolog
metabol
disord
sigel
et
al
interestingli
human
nasal
fluid
contain
major
lipid
class
well
apoai
contribut
inher
antibacteri
activ
human
mucos
defenc
carmo
et
al
moreov
host
immun
respons
enhanc
highdens
lipoprotein
compon
phagocyt
activ
markedli
improv
apoa
particular
tanaka
et
al
apo
interfer
aureu
switch
colon
invas
pathogen
antagon
aureu
quorumsens
system
upregul
gene
requir
invas
infect
antagon
mediat
bind
apob
aureu
autoinduc
pheromon
prevent
attach
pheromon
bacteri
cell
subsequ
suppress
signal
transduct
receptor
peterson
et
al
sera
famili
hypercholesterolaem
patient
elev
apob
could
suppress
lipoteicho
acid
lta
induc
inflamm
human
bind
lta
aureu
sigel
et
al
part
innat
immun
respons
infect
human
serum
apob
bind
mask
quorumsignal
molecul
aureu
autoinduc
peptid
aip
lead
transcript
downregul
agr
express
aureu
jame
et
al
human
serum
apoa
apoc
directli
inhibit
growth
coagulaseneg
staphylococci
vitro
promot
innat
defenc
mechan
normal
immunocompromis
individu
tada
et
al
although
apod
may
play
role
aureu
infect
neuroprotect
function
human
coronavirusinduc
enceph
carmo
et
al
moreov
serum
apoh
bind
staphylococc
sbi
cellsurfac
protein
express
divers
level
differ
aureu
strain
zhang
et
al
apo
major
cholesterol
carrier
divers
function
regul
lipid
transport
glucos
metabol
mitochondri
function
neuron
signal
modul
neuroinflamm
well
possess
role
innat
immun
respons
liu
et
al
although
apo
bind
sever
cellsurfac
receptor
liu
et
al
interact
cellsurfac
protein
aureu
particularli
clfa
report
far
current
studi
identifi
apo
novel
ligand
aureu
surfac
protein
clfa
evalu
extent
apo
bind
clfa
molecular
level
well
microbi
cell
level
aureu
strain
aureu
wildtyp
clfasuffici
newman
strain
clfa
well
isogen
aureu
clfadefici
strain
clfa
genotyp
mcdevitt
et
al
use
wholecel
bind
assay
well
cellwallbind
experi
preserv
strain
singl
coloni
strain
inocul
ml
tryptic
soy
broth
tsb
mp
biomed
incub
h
uc
glycerol
ad
final
concentr
vv
tsb
cultur
fraction
ml
aliquot
steril
polypropylen
cryotub
sigmaaldrich
store
uc
arciola
et
al
experi
test
strain
grown
midexponenti
phase
od
uc
columbia
broth
supplement
wv
nacl
serum
plasma
normal
human
serum
plasma
made
describ
previous
cunnion
et
al
blood
healthi
human
volunt
agreement
institut
review
board
standard
protocol
eastern
virginia
medic
school
evm
irb
serum
pool
aliquot
frozen
uc
protein
antibodi
chemic
fraction
v
heat
shocktreat
bsa
obtain
fisher
scientif
recombin
clump
factor
rclfa
molecular
mass
kda
gener
escherichia
coli
purifi
previous
describ
hair
et
al
human
apo
kda
goat
antiapo
igg
antigoat
igg
horseradish
peroxidas
hrp
conjug
antibodi
purchas
emd
millipor
chemic
unless
otherwis
state
chemic
buffer
ingredi
obtain
sigmaaldrich
plasma
protein
bind
rclfa
bottom
immulon
plate
immunochemistri
technolog
coat
rclfa
mg
ml
previous
describ
hair
et
al
plate
block
wv
bsa
wash
vv
human
plasma
ad
dgvb
buffer
incub
well
wash
strip
wv
sd
strip
extract
run
sdspage
gel
sdspage
gel
stain
protein
use
sypro
rubi
accord
manufactur
instruct
ms
identif
human
protein
protein
band
excis
sypro
rubi
stain
sdspage
gel
process
liquid
chromatographi
electrospray
ioniz
tandem
mass
spectrometri
lcesmsm
previous
describ
hair
et
al
acquir
data
process
protein
identifi
use
mascot
daemon
client
applic
matrix
scienc
softwar
use
index
bacteri
subset
databas
nonredund
protein
databas
expasyswissprot
statist
analysi
strength
peptid
identif
perform
previous
describ
hair
et
al
combin
elisa
western
blot
analysi
cewa
assay
serum
apo
bind
rclfa
previous
describ
method
cewa
adapt
assess
apo
bind
rclfa
sharp
et
al
briefli
immulon
plate
coat
mg
aureu
rclfa
ml
carbon
buffer
ml
per
well
incub
uc
h
incub
well
rins
three
time
pbstween
pbst
solut
block
solut
wv
bsa
pbst
appli
ml
per
well
overnight
uc
well
wash
three
time
pbst
incub
vv
human
serum
pb
ml
per
well
room
temperatur
h
well
wash
three
time
pbst
strip
retain
protein
ml
wv
sd
buffer
control
well
contain
wv
bsa
pb
sdspage
western
blot
solut
strip
protein
mix
reduc
sampl
buffer
heat
uc
min
load
onto
trishcl
mini
sdspage
gel
biorad
laboratori
electrophores
v
min
faghri
et
al
pagerul
plu
prestain
protein
ladder
thermo
scientif
size
rang
kda
magicmark
xp
western
protein
standard
invitrogen
size
rang
kda
human
apo
emd
millipor
chemic
use
experi
electrophoresi
protein
blot
pvdf
membran
emd
millipor
describ
elsewher
walsh
et
al
membran
incub
rotari
shaker
rpm
room
temperatur
h
goat
antiapo
antibodi
wash
pvdf
membran
three
time
trisbuff
salin
tween
tbst
solut
membran
incub
mous
antigoat
igg
antibodi
hrp
conjug
room
temperatur
rotari
shaker
rpm
min
follow
rins
tbst
three
time
develop
solut
immunstar
hrp
chemiluminesc
kit
biorad
laboratori
appli
membran
accord
manufactur
instruct
chemiluminesc
imag
captur
exposur
time
versadoc
imag
system
biorad
laboratori
optic
densitometri
analysi
perform
use
quantiti
one
analysi
softwar
biorad
wholecel
bind
assay
assay
perform
describ
elsewher
miajlov
et
al
modif
briefli
immulon
plate
coat
mg
purifi
human
apo
ml
carbon
buffer
ml
per
well
follow
incub
uc
h
coat
well
rins
twice
wv
bsa
pb
solut
surfac
block
solut
uc
h
bacteri
suspens
ml
per
well
cfu
ml
wv
bsa
pb
transfer
apoeco
well
plate
incub
h
room
temperatur
rotari
shaker
rpm
incub
well
wash
twice
pb
bound
cell
mechan
strip
pb
ml
per
well
harvest
cell
tenfold
serial
dilut
pb
plate
onto
muellerhinton
ii
agar
bd
incub
uc
h
masago
et
al
coloni
count
perform
describ
kuwahara
et
al
apo
bind
aureu
cell
wall
base
publish
describ
method
friberg
et
al
modif
aureu
strain
grown
midexponenti
phase
od
uc
columbia
broth
supplement
wv
nacl
cell
harvest
centrifug
g
min
wash
twice
steril
pb
resuspend
pb
contain
wv
bsa
pbsbsa
match
mcfarland
turbid
standard
thermo
scientif
remel
equival
cfu
ml
cell
suspens
incub
apo
mg
ml
h
uc
follow
centrifug
g
min
wash
twice
steril
pbsbsa
formerli
describ
method
sharp
cunnion
employ
prepar
cellwal
extract
brief
bacteri
cell
suspend
ml
digest
buffer
wv
raffinos
tri
ph
nacl
contain
mg
lysostaphin
sigmaaldrich
mg
dnase
sigmaaldrich
ml
proteas
inhibitor
roch
diagnost
cell
suspens
incub
uc
h
rotat
mix
protoplast
settl
centrifug
rpm
min
cellwal
protein
recov
supernat
cellwallbound
apo
assess
describ
sdspage
western
blot
pure
human
apo
use
control
immunodotblot
assay
establish
apo
calibr
curv
immunodotblot
techniqu
dhaliw
et
al
implement
short
methanoltr
pvdf
membran
load
escal
amount
purifi
apo
mg
follow
airdri
room
temperatur
dri
membran
block
wv
bsa
trisbuff
salin
tb
room
temperatur
rotari
shaker
rpm
h
follow
rins
three
time
tbst
solut
membran
incub
goat
antiapo
antibodi
h
rotari
shaker
rpm
room
temperatur
rins
three
time
tbst
mous
antigoat
igg
antibodi
hrp
conjug
incub
membran
room
temperatur
rotari
shaker
rpm
min
follow
rins
tbst
three
time
develop
solut
immunstar
hrp
chemiluminesc
kit
biorad
appli
membran
chemiluminesc
captur
exposur
time
versadoc
imag
system
biorad
densiti
chemiluminesc
signal
quantifi
express
count
cnt
mm
use
quantiti
one
analysi
softwar
biorad
convers
pvdf
membran
load
increas
amount
rclfa
mg
follow
airdri
bsa
mg
use
control
membran
incub
block
solut
tbsbsa
room
temperatur
h
shake
dilut
human
serum
vv
human
serum
tbsbsa
incub
membran
h
room
temperatur
rotari
shaker
rpm
follow
rins
tbst
three
time
membran
incub
goat
antiapo
antibodi
subsequ
mous
antigoat
igg
antibodi
hrp
conjug
describ
statist
analysi
quantit
assay
perform
triplic
mean
data
repres
graphic
result
analys
mannwhitney
nonparametr
test
linear
model
protein
interact
pearson
correl
coeffici
rclfa
bind
apo
determin
twotail
signific
level
data
output
analys
calcul
p
valu
consid
statist
signific
statist
analys
current
studi
perform
use
spss
version
spss
order
identifi
human
plasma
protein
would
bind
region
clfa
util
rclfa
incub
human
plasma
surfacebound
rclfa
elisa
plate
wash
extract
bound
protein
supernat
analys
sdspage
total
protein
stain
sypro
rubi
fig
five
predomin
band
could
easili
visual
uv
viewer
excis
process
msbase
protein
identif
number
uniqu
peptid
identifi
respect
protein
band
shown
tabl
number
peptid
identifi
includ
variant
peptid
differ
posttransl
modif
slightli
differ
retent
time
thu
exclud
minor
variant
peptid
identifi
apo
yield
nine
signific
peptid
tabl
apo
peptid
identifi
high
statist
signific
ie
peptid
score
expect
score
tandem
ms
data
peptid
show
continu
seri
b
fragment
ion
valid
ident
peptid
provid
coverag
map
demonstr
good
coverag
high
degre
confid
identif
fig
data
strongli
suggest
apo
could
novel
ligand
clfa
order
confirm
serum
apo
bind
clfa
assay
serum
apo
bind
rclfa
cewa
briefli
rclfa
coupl
immulon
plate
incub
human
serum
wash
retain
protein
strip
assay
western
blot
analysi
probe
apo
well
coat
rclfa
show
mark
bind
apo
dilut
human
serum
vv
human
serum
pb
aureu
rclfa
wherea
serum
apo
bind
bsa
control
could
detect
experi
standard
human
apo
use
confirm
protein
ident
human
serum
apo
band
appear
expect
molecular
mass
kda
reduc
sdspage
condit
shown
fig
establish
apo
calibr
curv
immunodotblot
techniqu
employ
blot
increas
amount
apo
mg
pvdf
membran
follow
probe
apo
construct
calibr
curv
show
good
linear
r
apo
mg
densiti
chemiluminesc
cnt
mm
shown
fig
quantit
character
bind
relationship
serum
apo
rclfa
escal
amount
rclfa
mg
dot
blot
onto
membran
incub
human
serum
rins
subsequ
membran
incub
goat
antiapo
antibodi
follow
probe
apo
fig
neglig
apo
bound
bsa
control
bind
apo
rclfa
demonstr
two
phase
bind
kinet
linear
phase
rclfa
concentr
rang
mg
b
plateau
phase
rclfa
concentr
rang
mg
correl
optic
densitometri
valu
apo
calibr
curv
amount
apo
mg
bound
rclfa
could
determin
shown
fig
c
linear
model
apo
human
serum
bind
rclfa
mg
demonstr
statist
signific
p
posit
correl
stoichiometr
bind
ratio
rclfa
apo
highest
pearson
correl
coeffici
shown
tabl
examin
bind
capabl
human
apo
bacteri
cell
surfac
midexponenti
phase
clfasuffici
wildtyp
aureu
clfa
isogen
clfadefici
mutant
clfa
incub
human
apo
mg
ml
wash
cellwal
extract
prepar
westernblot
analysi
cellwal
prepar
wildtyp
clfa
show
presenc
human
apo
characterist
band
kda
howev
bind
human
apo
cell
wall
clfadefici
mutant
clfa
could
detect
experiment
condit
fig
order
evalu
extent
aureu
surfac
express
clfa
contribut
apo
bind
perform
wholecel
bind
assay
wildtyp
clfaexpress
clfa
aureu
newman
strain
compar
isogen
clfadefici
clfa
mutant
wildtyp
aureu
clfa
clfadefici
strain
clfa
suspens
incub
apoeco
immulon
plate
wash
bound
cell
stripe
coloni
count
perform
agar
plate
techniqu
result
depict
fig
indic
statist
signific
determin
mannwhitney
nonparametr
test
lower
bind
clfadefici
strain
clfa
compar
wildtyp
clfa
aureu
premier
human
pathogen
caus
lifethreaten
diseas
complex
pathogenesi
hawkin
et
al
includ
attach
evas
immun
defenc
sharp
et
al
current
studi
identifi
apo
potenti
new
ligand
aureu
surfaceexpress
virul
factor
clfa
aureu
strain
express
clfa
conserv
surfac
protein
initi
describ
abil
promot
precipit
clump
reaction
staphylococci
vitro
via
bind
solubl
fibrinogen
mcadow
et
al
clfa
clearli
demonstr
major
virul
factor
mani
anim
model
includ
anim
model
endocard
septic
arthriti
hu
et
al
josefsson
et
al
moreillon
et
al
howev
extent
clfaenhanc
virul
mediat
interact
fibrinogen
mcadow
et
al
complement
regul
factor
hair
et
al
hair
et
al
serum
protein
remain
unresolv
plasma
apo
lipid
particip
host
innat
immun
differ
pathogen
singh
et
al
zhang
et
al
apo
possess
multipl
immun
regulatori
function
includ
modul
macrophag
function
suppress
cell
prolifer
upregul
product
platelet
nitric
oxid
facilit
lipid
antigen
present
molecul
natur
killer
cell
moreov
inflammatori
cytokin
either
upregul
downregul
product
apo
variou
tissu
type
highlight
complex
role
apo
cytokin
variou
diseas
zhang
et
al
apo
believ
mediat
nonlipid
associ
function
bind
cellsurfac
receptor
jofremonseni
et
al
earlier
studi
employ
apoedefici
mice
reveal
increas
suscept
klebsiella
pneumonia
infect
de
bont
et
al
well
elev
mortal
listeria
monocytogen
compar
wildtyp
mice
roselaar
daugherti
furthermor
serum
apoedefici
mice
demonstr
inabl
neutral
lp
demonstr
consider
enhanc
lethal
lpsinduc
endotoxaemia
compar
wildtyp
mice
van
oosten
et
al
apo
defici
also
associ
delay
emerg
adapt
immun
tuberculosi
apoedefici
mice
extrem
suscept
tuberculosi
marten
et
al
peptid
analogu
receptorbind
region
apo
apo
dimer
tandem
repeat
peptid
apo
dp
could
reproduc
biolog
properti
apo
demonstr
antimicrobi
activ
aureu
pseudomona
aeruginosa
herp
simplex
virus
well
human
immunodefici
viru
biolog
activ
attribut
part
prevent
earli
stage
microbi
attach
mammalian
cell
dobson
et
al
moreov
novel
peptid
deriv
human
apo
apo
dplw
show
broadspectrum
antibacteri
activ
notic
antimicrobi
activ
emerg
aureu
biofilm
forb
et
al
current
studi
identifi
use
ms
apo
major
plasma
protein
bind
surfacecoupl
recombin
clfa
confirm
elucid
bind
human
apo
clfa
util
purifi
serum
apo
evalu
bind
rclfa
cewa
dot
blot
assay
furthermor
isogen
clfadefici
aureu
strain
reveal
statist
signific
decreas
bind
human
serum
apo
compar
wildtyp
clfasuffici
strain
western
blot
analysi
reveal
purifi
human
apo
bound
bacteri
cell
surfac
wildtyp
clfasuffici
strain
clfa
bind
detect
isogen
clfadefici
strain
clfa
togeth
data
suggest
apo
may
novel
ligand
clfa
previou
studi
describ
suggest
apo
play
role
host
defenc
mani
pathogen
tabl
linear
model
protein
interact
depend
rclfa
mg
bind
apo
dilut
human
serum
vv
human
serum
tbsbsa
determin
spss
version
spss
calcul
linear
model
base
chemiluminesc
densiti
obtain
immunodotblot
assay
serum
apo
bind
rclfa
quantif
chemiluminesc
densiti
correspond
apo
mg
perform
use
apo
calibr
curv
hair
et
al
could
potenti
bind
apo
remot
bacteri
surfac
scenario
clfa
sequestr
apo
could
mediat
host
defenc
evas
mechan
aureu
previou
studi
apoederiv
peptid
suggest
apo
may
possess
antibiofilm
effect
aureu
host
defenc
mechan
potenti
modul
bind
clfa
forb
et
al
altern
also
possibl
apo
bind
virul
factor
clfa
could
potenti
mask
virul
factor
interact
known
ligand
fibrinogen
factor
thu
moder
clfamedi
virul
howev
apo
bind
clfa
major
mechan
immunolog
control
aureu
would
expect
clfadefici
strain
demonstr
increas
virul
opposit
true
clfadefici
strain
markedli
less
virul
suggest
apo
bind
clfa
unlik
contribut
immunolog
control
aureu
thu
appear
like
aureu
may
sequest
apo
via
clfa
immun
evas
tactic
mean
increas
virul
via
anoth
mechan
current
studi
identifi
novel
ligand
apo
known
aureu
virul
factor
clfa
bind
apo
clfa
demonstr
molecular
cellular
level
futur
studi
focu
elucid
whether
clfa
bind
apo
enhanc
inhibit
aureu
virul
mechan
occur
addit
vivo
studi
util
apoeknockout
anim
model
clfadefici
aureu
strain
requir
address
indepth
mechan
impact
clfaapo
interact
aureu
pathogenesi
cell
signal
neuroprotect
effect
apolipoprotein
human
coronaviru
enceph
mice
j
neurosci
